Submission Details

Submitter:

Classification:
Definitive
GENCC:100001
Gene:
Disease:
autoinflammatory syndrome, familial, X-linked, Behcet-like 2
Mode Of Inheritance:
X-linked
Evaluated Date:
06/25/2025
Evidence/Notes:

ELF4 was first reported in relation to X-linked inheritance autoinflammatory syndrome, familial Behcet-like 2 in 2021 (Tyler et al., PMID: 34326534). X-linked familial Behcet-like autoinflammatory syndrome-2 is an X-linked recessive disorder characterized by inflammatory symptoms present in males within the first decade of life. Affected males most often present with oral mucosal ulceration and skin inflammation. Other variable features include gastrointestinal ulceration, arthritis, recurrent fevers, and iron deficiency anemia.

ELF-4 deficiency is also known as X-linked deficiency in ELF4 (DEX). It is characterized by mucosal inflammation and features resembling inflammatory bowel disease (IBD), in addition to the Behcet’s phenotype. ELF4 is a transcription factor that regulates immune responses in macrophages. The loss of ELF4 leads to hyperinflammatory response in macrophages, specifically with regard to IL-17 and TREM-1 signaling, which contributes to the phenotype. TREM-1 blockade has been shown to mitigate inflammation and intestinal pathology in ELF-4-deficient mouse models. More recently it has been shown that ELF4 also regulates the inflammatory potential of CD4+ T cells (Bender et al, The Journal of Immunology, May 2024, https://doi.org/10.4049/jimmunol.212.supp.1259.5567). The clinical phenotype of ELF-4 deficiency includes fevers, oral and GI ulcers, abdominal pain, diarrhea, and arthritis. DEX is primarily observed in males though skewed X-chromosome inactivation and disease has been reported in females (Zhao R et al, PMID: 39976696).

Seven variants (missense, nonsense, frameshift) that have been reported in nine probands in four publications (PMIDs: 34326534, 35266071, 38231408, 36823308) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity appears to be loss of function.

This gene-disease relationship is also supported by experimental evidence (e.g. animal models, expression studies) (PMIDs: 35266071, 34326534). Mouse studies including both knock-in (W250S mice; equivalent to the human W251S) and knock-out (Elf4 KO) mice showed that there was reduced perforin expression in cytotoxic T lymphocytes. Both the Elf4 KO and W250S mice indicate that the patient-derived ELF4 variants are loss-of-function. Further, mice harboring the W230R missense variant (equivalent to the human W231R) showed significantly decreased viral clearance compared to those from WT mice. Bone marrow-derived macrophage (BMDM) from mutant mice showed similar impairment suggesting impaired ability for viral clearance.

In summary, there is definitive evidence supporting the relationship between ELF4 and X-linked inheritance autoinflammatory syndrome, familial Behcet-like 2. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time This classification was approved by the ClinGen PIRD GCEP on the meeting date Jne 9, 2025 (SOP Version 10.1).

PubMed IDs:
34326534 35266071 36823308 38022496 38231408
Public Report:
Assertion Criteria:
Submitter Submitted Date:
12/05/2025

The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.